Oncology Institute Leadership

Richy Agajanian, MD is a Founder, CCO at ONCOLOGY INSTITUTE, INC..

Brad Hively is the Chief Executive Officer of The Oncology Institute of Hope and Innovation. Brad joined The Oncology Institute as a member of its Board of Directors in 2018 and assumed the role of CEO in 2019. He brings over 20 years of executive leadership and healthcare experience to The Oncology Institute. Before joining The Oncology Institute, Brad was President of Health Essentials. Through its IPA (Health Essentials Physician Network), its Medical Group (GeriNet), and its eight hospices, Health Essentials provided high-touch, value-based care for patients with advanced illness. Before Health Essentials, Brad was Senior Vice President of Operations at Heritage Provider Network. Heritage is one of the largest, most progressive physician groups in the country. Through its network of over 35,000 physicians, Heritage manages care for approximately one million patients on an at-risk basis. At Heritage, Brad held several positions of increasing responsibility, including leadership and management of multiple IPAs and staff-model physician groups.

Dan Virnich, MD is a COO at ONCOLOGY INSTITUTE, INC..

Carolina Rosales is an Executive Assistant to Chief Executive Officer | Administrative Supervisor at ONCOLOGY INSTITUTE, INC. and is based in Cerritos, California. She has worked as Executive Assistant to VP of PACE Marketing & Operations at AltaMed Health Services; Executive Assistant to VP, Emerging Markets- Sales & Marketing at KARL STORZ ENDOSCOPY-AMERICA, INC.; and Executive Assistant to Chief Financial Officer at Wedbush Securities. Carolina attended University of California, Los Angeles; Pepperdine University; and Theodore Roosevelt Magnet High School.

Chris Wolfe is a CFO/Secy at ONCOLOGY INSTITUTE, INC.; Board Member at PERMANENT GENERAL COMPANIES, INC.; and CFO/Secretary at DA32 LIFE SCIENCE TECH ACQUISITION CORP.. He has worked as Principal at Capital Z Partners Management LLC, Board Member at UNIVERSAL AMERICAN CORP, and Partner at Capital Z Partners Management LLC. Chris attended Harvard University.

Josh Rademacher is a CDO at ONCOLOGY INSTITUTE, INC..

Matt Miller is a Chief Administrative Officer at ONCOLOGY INSTITUTE, INC. and is based in Greater Los Angeles Area. He has worked as Business Analyst, Product at Pure Markets Inc; Senior Vice President, Clinical Strategy and Head of Innovation at Landmark Health; and Chief Operating Officer at Altais. Matt studied at David Geffen School of Medicine at UCLA, Harvard University, and UCLA Anderson School of Management.

Maureen Murphy is a CPO at ONCOLOGY INSTITUTE, INC..

Scott Dalgleish is a CFO at ONCOLOGY INSTITUTE, INC..

Yale Podnos, MD is a CMO at ONCOLOGY INSTITUTE, INC..

Richy Agajanian, MD is a Founder, CCO at ONCOLOGY INSTITUTE, INC..

Brad Hively is the Chief Executive Officer of The Oncology Institute of Hope and Innovation. Brad joined The Oncology Institute as a member of its Board of Directors in 2018 and assumed the role of CEO in 2019. He brings over 20 years of executive leadership and healthcare experience to The Oncology Institute. Before joining The Oncology Institute, Brad was President of Health Essentials. Through its IPA (Health Essentials Physician Network), its Medical Group (GeriNet), and its eight hospices, Health Essentials provided high-touch, value-based care for patients with advanced illness. Before Health Essentials, Brad was Senior Vice President of Operations at Heritage Provider Network. Heritage is one of the largest, most progressive physician groups in the country. Through its network of over 35,000 physicians, Heritage manages care for approximately one million patients on an at-risk basis. At Heritage, Brad held several positions of increasing responsibility, including leadership and management of multiple IPAs and staff-model physician groups.